47
Cue Biopharma, Inc. raises $50M under Reg D
Company raise · Closed · Offering $50M · Sold $50M · BOSTON, MA · filed 2026-07-22
57
Cue Biopharma, Inc. raises $30M under Reg D
Company raise · Closed · BOSTON, MA · Form D filed 2026-05-14
$10M+ raiseFirst raise on EDGARPlacement agent engaged
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Patrick Verheyen | Director |
| Daniel Baker | Executive Officer |
| Peter Kiener | Director |
| Frank Morich | Director |
| Pamela D. Garzone | Director |
| Colin Sandercock | Executive Officer |
| Jill M. Broadfoot | Director |
| Shao-Lee Lin | Executive Officer, Director |
| Pasha Sarraf | Director |
Signed by Sumita Ray, JD, Chief Legal & Compliance Officer.
Placement agents / sales compensation: Newbridge Securities Corporation
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.